HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nael Martini Manjit S. Bains Michael E. Burt Patricia M. McCormack Valerie W. Rusch Robert J. Ginsberg Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martini, N. Articles by Ginsberg, R. J. Search for Related Content PubMed PubMed Citation Articles by Martini, N. Articles by Ginsberg, R. J.

J Thorac Cardiovasc Surg 1994;107:1-7
© 1994 Mosby, Inc.

GENERAL THORACIC SURGERY

Treatment and prognosis in bronchial carcinoids involving regional lymph nodes

New York, N.Y.

Address for reprints: N. Martini, MD, 1275 York Ave., New York, NY 10021.

Abstract

From 1953 to 1992, 25 patients were surgically treated for bronchial carcinoids with metastases to regional lymph nodes (N1 or N2). The tumors were located centrally, involving main or lobar bronchi in 12 patients and were peripheral in 13. Histologically, 12 of the carcinoids were classified as typical and 13 as atypical (neuroendocrine carcinoma). Pneumonectomy was performed in 11 patients, sleeve lobectomy in one, lobectomy in seven and bilobectomy in six. A formal mediastinal lymph node dissection was done in 20 patients. At final staging, 10 had N1 disease and 15 had N2. No adjuvant treatment was given to the 10 patients with N1 disease. External radiation therapy was given after the operation to 9 of 15 patients with N2 disease. The overall 5-year survival (Kaplan-Meier) was 75% (median 62 months). No difference in survival was found between patients with N1 or N2 disease. However, survival and recurrence rate differed between typical and atypical carcinoids. In typical carcinoids, the 5-year survival was 92% and, in atypical carcinoids, it was 60% (p = 0.02). We conclude that complete resection for bronchial carcinoids results in long-term survival despite the presence of regional lymph node metastases. Recurrence appears to depend more on cell type than nodal status. Postoperative radiation therapy does not appear to be beneficial. (J THORAC CARDIOVASC SURG 1994;107:1-7)

This article has been cited by other articles:

				H. A.P. Brokx, E. K. Risse, M. A. Paul, K. Grunberg, R. P. Golding, P. W.A. Kunst, J.-P. Eerenberg, J. C. van Mourik, P. E. Postmus, W. J. Mooi, et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 973 - 978. [Abstract] [Full Text] [PDF]

				M. Garcia-Yuste, J. M. Matilla, A. Cueto, J. M. R. Paniagua, G. Ramos, M. A. Canizares, I. Muguruza, and Members of the Spanish Multi-centric Study of Neur Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 192 - 197. [Abstract] [Full Text] [PDF]

				B. D. Kozower, R. Jarrett, S. Bhalla, and G. A. Patterson Clinical-pathologic conference in general thoracic surgery: Carinal resection for endobronchial grade I neuroendocrine carcinoma. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1219 - 1222. [Full Text] [PDF]

				E. Lim, Y. K. Yap, B. L. De Stavola, A. G. Nicholson, and P. Goldstraw The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 969 - 972. [Abstract] [Full Text] [PDF]

				P. L. Filosso, A. Arslanian, N. Palestini, A. Farnetti, M. Papotti, M. Bongiovanni, R. Giobbe, and E. Ruffini Thyroid metastasis after resection of atypical bronchial carcinoid J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1840 - 1843. [Full Text] [PDF]

				G. Cardillo, F. Sera, M. Di Martino, P. Graziano, R. Giunti, L. Carbone, F. Facciolo, and M. Martelli Bronchial carcinoid tumors: nodal status and long-term survival after resection Ann. Thorac. Surg., May 1, 2004; 77(5): 1781 - 1785. [Abstract] [Full Text] [PDF]

				P. L. Filosso Large-cell neuroendocrine carcinoma (LCNC) of the lung: a dilemma Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 672 - 672. [Full Text] [PDF]

				R. Hage, A. B. de la Riviere, C.A. Seldenrijk, and J.M. M. van den Bosch Update in Pulmonary Carcinoid Tumors: A Review Article Ann. Surg. Oncol., July 1, 2003; 10(6): 697 - 704. [Abstract] [Full Text] [PDF]

				P. L. Filosso Large cell neuroendocrine carcinoma of the lung: What we have to do J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1182 - 1183. [Full Text] [PDF]

				J. Zacharias, A. G. Nicholson, G. P. Ladas, and P. Goldstraw Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection Ann. Thorac. Surg., February 1, 2003; 75(2): 348 - 352. [Abstract] [Full Text] [PDF]

				H. Codrington, T. Sutedja, R. Golding, J. van Mourik, E. Risse, and P. E. Postmus Unusual Pulmonary Lesions: Case 2. Endobronchial Carcinoid of the Lung J. Clin. Oncol., June 1, 2002; 20(11): 2747 - 2748. [Full Text] [PDF]

				M.-Y. Jeung, B. Gasser, A. Gangi, D. Charneau, X. Ducroq, R. Kessler, E. Quoix, and C. Roy Bronchial Carcinoid Tumors of the Thorax: Spectrum of Radiologic Findings RadioGraphics, March 1, 2002; 22(2): 351 - 365. [Abstract] [Full Text] [PDF]

				P. L. Filosso, O. Rena, G. Donati, C. Casadio, E. Ruffini, E. Papalia, A. Oliaro, and G. Maggi Bronchial carcinoid tumors: Surgical management and long-term outcome J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 303 - 309. [Abstract] [Full Text] [PDF]

				W. A. Cooper, V. H. Thourani, A. A. Gal, R. B. Lee, K. A. Mansour, and J. I. Miller The Surgical Spectrum of Pulmonary Neuroendocrine Neoplasms Chest, January 1, 2001; 119(1): 14 - 18. [Abstract] [Full Text] [PDF]

				M. El Jamal, A.G. Nicholson, and P. Goldstraw The feasibility of conservative resection for carcinoid tumours: is pneumonectomy ever necessary for uncomplicated cases? Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 301 - 306. [Abstract] [Full Text] [PDF]

				M. Garcia-Yuste, J. M. Matilla, T. Alvarez-Gago, J. L. Duque, F. Heras, L. J. Cerezal, and G. Ramos Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study Ann. Thorac. Surg., July 1, 2000; 70(1): 258 - 263. [Abstract] [Full Text] [PDF]

				M. L. Rosado de Christenson, G. F. Abbott, W. M. Kirejczyk, J. R. Galvin, and W. D. Travis From the Archives of the AFIP: Thoracic Carcinoids: Radiologic-Pathologic Correlation RadioGraphics, May 1, 1999; 19(3): 707 - 736. [Abstract] [Full Text] [PDF]

				G. Massard, P. Thomas, P. Fuentes, and J.-M. Wihlm Reply Ann. Thorac. Surg., November 1, 1998; 66(5): 1870 - 1871. [Full Text] [PDF]

				X. Ducrocq, P. Thomas, G. Massard, P. Barsotti, R. Giudicelli, P. Fuentes, and J.-M. Wihlm Operative Risk and Prognostic Factors of Typical Bronchial Carcinoid Tumors Ann. Thorac. Surg., May 1, 1998; 65(5): 1410 - 1414. [Abstract] [Full Text] [PDF]

				B. B. Sheppard, D. M. Follette, and F. J. Meyers Giant Carcinoid Tumor of the Lung Ann. Thorac. Surg., March 1, 1997; 63(3): 851 - 852. [Abstract] [Full Text]

				V. W. Rusch, D. S. Klimstra, and E. S. Venkatraman Molecular Markers Help Characterize Neuroendocrine Lung Tumors Ann. Thorac. Surg., September 1, 1996; 62(3): 798 - 809. [Abstract] [Full Text]